NVCT Q1 2026 Earnings Narrower Loss Beats Estimates as Clinical Pipeline Advances PM Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Pricing and Volume Mix CMCT Q3 2024 Earnings Significant EPS Miss Amidst Challenging Market Conditions RERE Q1 2026 Earnings EPS Crushes Estimates by Over 700 on Operational Strength LAMR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response TONX Q1 2026 Earnings Massive EPS Beat Drives 62 Stock Surge